Willem Onkenhout

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Abnormal VLCADD newborn screening resembling MADD in four neonates with decreased riboflavin levels and VLCAD activity.

Abnormal VLCADD newborn screening resembling MADD in four neonates with decreased riboflavin levels and VLCAD activity.

Journal: JIMD reports

Published: December 22, 2020

Untargeted Metabolomics-Based Screening Method for Inborn Errors of Metabolism using Semi-Automatic Sample Preparation with an UHPLC- Orbitrap-MS Platform.

Untargeted Metabolomics-Based Screening Method for Inborn Errors of Metabolism using Semi-Automatic Sample Preparation with an UHPLC- Orbitrap-MS Platform.

Journal: Metabolites

Published: September 30, 2019

Neurotoxicity including posterior reversible encephalopathy syndrome after initiation of calcineurin inhibitors in transplanted methylmalonic acidemia patients: Two case reports and review of the literature.

Neurotoxicity including posterior reversible encephalopathy syndrome after initiation of calcineurin inhibitors in transplanted methylmalonic acidemia patients: Two case reports and review of the literature.

Journal: JIMD reports

Published: September 20, 2019

Fibroblast growth factor 21 as a biomarker for long-term complications in organic acidemias.

Fibroblast growth factor 21 as a biomarker for long-term complications in organic acidemias.

Journal: Journal of inherited metabolic disease

Published: April 25, 2018

Neonatal screening for profound biotinidase deficiency in the Netherlands: consequences and considerations.

Neonatal screening for profound biotinidase deficiency in the Netherlands: consequences and considerations.

Journal: European journal of human genetics : EJHG

Published: February 05, 2016

Cystathionine Levels in Patients With Huntington Disease.

Cystathionine Levels in Patients With Huntington Disease.

Journal: PLoS currents

Published: October 06, 2015

Pilot Experience with an External Quality Assurance Scheme for Acylcarnitines in Plasma/Serum.

Pilot Experience with an External Quality Assurance Scheme for Acylcarnitines in Plasma/Serum.

Journal: JIMD reports

Published: September 15, 2015

Comments on 'Infantile hypophosphatasia without bone deformities presenting with severe pyridoxine-resistant seizures' in Molecular Genetics and Metabolism' 2014 Mar;111(3):404-7 by M.G. de Roo, N.G. Abeling, C.B. Majoie, A.M. Bosch, J.H. Koelman, J.M. Cobben, M. Duran, B.T. Poll-The.

Comments on 'Infantile hypophosphatasia without bone deformities presenting with severe pyridoxine-resistant seizures' in Molecular Genetics and Metabolism' 2014 Mar;111(3):404-7 by M.G. de Roo, N.G. Abeling, C.B. Majoie, A.M. Bosch, J.H. Koelman, J.M. Cobben, M. Duran, B.T. Poll-The.

Journal: Molecular genetics and metabolism reports

Published: April 08, 2014

Showing 1-8 of 8

Last Updated: 09/26/2026